LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES

This adverse event was reported 48083 times

These drugs are most commonly taken by patients reporting LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES:

# Drug Count
0 PREDNISONE 9177
1 ADALIMUMAB 6588
2 METHOTREXATE SODIUM 6097
3 ALBUTEROL SULFATE 5850
4 METHOTREXATE 5361
5 ETANERCEPT 4774
6 TOFACITINIB 4429
7 MEPOLIZUMAB 4281
8 TOCILIZUMAB 3726
9 ABATACEPT 3690
See all common drugs associated with LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLIMUMAB 2020 0.1604
1 CICLESONIDE 1799 0.1309
2 INFLIXIMAB-DYYB 410 0.1190
3 ERGOCALCIFEROL 3537 0.1190
4 GOLD 528 0.0909
5 MEPOLIZUMAB 4281 0.0849
6 DESOXIMETASONE 1209 0.0627
7 TOFACITINIB CITRATE 744 0.0555
8 CORTISONE ACETATE 658 0.0526
9 SULFASALAZINE 3660 0.0494
See all drugs enriched for association with LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 4281 6.2224
1 Provitamin D2 Compound [EPC] 3537 0.1189
2 Guanylate Cyclase-C Agonist [EPC] 142 0.0684
3 Anthelmintic [EPC] 151 0.0519
4 Endoglycosidase [EPC] 84 0.0453
5 Aminosalicylate [EPC] 4003 0.0397
6 Antihypoglycemic Agent [EPC] 164 0.0382
7 Antirheumatic Agent [EPC] 3557 0.0336
8 Interleukin-1 Receptor Antagonist [EPC] 566 0.0335
9 Interleukin-6 Receptor Antagonist [EPC] 4617 0.0333
See all drug classes enriched for association with LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES